company background image
SONX

Sonendo NYSE:SONX Stock Report

Last Price

US$1.63

Market Cap

US$43.4m

7D

-12.4%

1Y

n/a

Updated

14 Aug, 2022

Data

Company Financials +
SONX fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health3/6
Dividends0/6

SONX Stock Overview

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada.

Sonendo Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sonendo
Historical stock prices
Current Share PriceUS$1.63
52 Week HighUS$12.24
52 Week LowUS$1.40
Beta0
1 Month Change-9.44%
3 Month Change-40.51%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-82.28%

Recent News & Updates

Shareholder Returns

SONXUS Medical EquipmentUS Market
7D-12.4%1.9%3.2%
1Yn/a-19.1%-10.2%

Return vs Industry: Insufficient data to determine how SONX performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how SONX performed against the US Market.

Price Volatility

Is SONX's price volatile compared to industry and market?
SONX volatility
SONX Average Weekly Movement12.2%
Medical Equipment Industry Average Movement9.4%
Market Average Movement7.7%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: SONX is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: SONX's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2006234Bjarne Bergheimhttps://sonendo.com

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of EDTA that is used to help debride and disinfect the root canal system.

Sonendo Fundamentals Summary

How do Sonendo's earnings and revenue compare to its market cap?
SONX fundamental statistics
Market CapUS$43.38m
Earnings (TTM)-US$57.10m
Revenue (TTM)US$37.36m

1.2x

P/S Ratio

-0.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SONX income statement (TTM)
RevenueUS$37.36m
Cost of RevenueUS$28.03m
Gross ProfitUS$9.33m
Other ExpensesUS$66.44m
Earnings-US$57.10m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-2.15
Gross Margin24.98%
Net Profit Margin-152.85%
Debt/Equity Ratio59.2%

How did SONX perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is SONX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SONX?

Other financial metrics that can be useful for relative valuation.

SONX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.6x
Enterprise Value/EBITDA-0.4x
PEG Ration/a

Price to Sales Ratio vs Peers

How does SONX's PS Ratio compare to its peers?

SONX PS Ratio vs Peers
The above table shows the PS ratio for SONX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average8.4x
EAR Eargo
12.3x34.8%US$44.5m
SCND Scientific Industries
3.7x52.8%US$41.3m
DCTH Delcath Systems
10.9x59.9%US$41.3m
ECOR electroCore
6.6x38.8%US$46.7m
SONX Sonendo
1.2x34.9%US$43.4m

Price-To-Sales vs Peers: SONX is good value based on its Price-To-Sales Ratio (1.2x) compared to the peer average (8.4x).


Price to Earnings Ratio vs Industry

How does SONX's PE Ratio compare vs other companies in the US Medical Equipment Industry?

Price-To-Sales vs Industry: SONX is good value based on its Price-To-Sales Ratio (1.2x) compared to the US Medical Equipment industry average (4.4x)


Price to Sales Ratio vs Fair Ratio

What is SONX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SONX PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.2x
Fair PS Ratio2.3x

Price-To-Sales vs Fair Ratio: SONX is good value based on its Price-To-Sales Ratio (1.2x) compared to the estimated Fair Price-To-Sales Ratio (2.3x).


Share Price vs Fair Value

What is the Fair Price of SONX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SONX's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SONX's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies

Future Growth

How is Sonendo forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


39.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SONX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SONX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SONX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SONX's revenue (34.9% per year) is forecast to grow faster than the US market (7.9% per year).

High Growth Revenue: SONX's revenue (34.9% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SONX is forecast to be unprofitable in 3 years.


Discover growth companies

Past Performance

How has Sonendo performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-26.4%

Last years earnings growth

Earnings and Revenue History

Quality Earnings: SONX is currently unprofitable.

Growing Profit Margin: SONX is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if SONX's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare SONX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SONX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.5%).


Return on Equity

High ROE: SONX has a negative Return on Equity (-126.8%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is Sonendo's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: SONX's short term assets ($71.7M) exceed its short term liabilities ($14.3M).

Long Term Liabilities: SONX's short term assets ($71.7M) exceed its long term liabilities ($28.6M).


Debt to Equity History and Analysis

Debt Level: SONX has more cash than its total debt.

Reducing Debt: Insufficient data to determine if SONX's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SONX has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: SONX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 6.8% each year


Discover healthy companies

Dividend

What is Sonendo current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate SONX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SONX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SONX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SONX's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as SONX has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

4.6yrs

Average management tenure


CEO

Bjarne Bergheim (47 yo)

14.58yrs

Tenure

US$3,205,894

Compensation

Mr. Bjarne Bergheim has been the Chief Executive Officer, President and a Director of Sonendo, Inc since 2008. Mr. Bergheim was our first employee and previously served as our Chief Operating Officer from...


CEO Compensation Analysis

Compensation vs Market: Bjarne's total compensation ($USD3.21M) is above average for companies of similar size in the US market ($USD759.99K).

Compensation vs Earnings: Bjarne's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: SONX's management team is considered experienced (4.6 years average tenure).


Board Members

Experienced Board: SONX's board of directors are considered experienced (8.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: SONX insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: SONX only recently listed within the past 12 months.


Top Shareholders

Company Information

Sonendo, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Sonendo, Inc.
  • Ticker: SONX
  • Exchange: NYSE
  • Founded: 2006
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$43.384m
  • Shares outstanding: 26.62m
  • Website: https://sonendo.com

Number of Employees


Location

  • Sonendo, Inc.
  • 26061 Merit Circle
  • Suite 102
  • Laguna Hills
  • California
  • 92653
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/14 00:00
End of Day Share Price2022/08/12 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.